General Information of Drug (ID: DMXDTPL)

Drug Name
PMID22902653C30 Drug Info
Synonyms GTPL8118; BDBM50390789
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
58688690
TTD Drug ID
DMXDTPL

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID22902653C31 DMWVTAE Discovery agent N.A. Investigative [2]
PMID22902653C35 DMLVKPG Discovery agent N.A. Investigative [2]
PMID19831390C14 DMIECOF Discovery agent N.A. Investigative [3]
PMID19831390C22m DM8T6VG Discovery agent N.A. Investigative [3]
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID22902653C31 DMWVTAE Discovery agent N.A. Investigative [2]
PMID22902653C35 DMLVKPG Discovery agent N.A. Investigative [2]
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID22902653C31 DMWVTAE Discovery agent N.A. Investigative [2]
PMID22902653C35 DMLVKPG Discovery agent N.A. Investigative [2]
Drug Name Drug ID Indication ICD 11 Highest Status REF
RKI-1447 DMGTAWC Discovery agent N.A. Investigative [4]
PMID22902653C31 DMWVTAE Discovery agent N.A. Investigative [2]
PMID22902653C35 DMLVKPG Discovery agent N.A. Investigative [2]
PMID19831390C14 DMIECOF Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
LIM domain kinase-1 (LIMK-1) TTWL9TY LIMK1_HUMAN Inhibitor [2]
LIM domain kinase-2 (LIMK-2) TTASMD8 LIMK2_HUMAN Inhibitor [2]
Testis-specific kinase 1 (TESK1) TTWKT3Y TESK1_HUMAN Inhibitor [2]
Testis-specific kinase 2 (TESK2) TTRMD8U TESK2_HUMAN Inhibitor [2]

References

1 Cofilin phosphorylation and actin reorganization activities of testicular protein kinase 2 and its predominant expression in testicular Sertoli cells. J Biol Chem. 2001 Aug 17;276(33):31449-58.
2 Modulation of cofilin phosphorylation by inhibition of the Lim family kinases. Bioorg Med Chem Lett. 2012 Sep 15;22(18):5995-8.
3 Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma. J Med Chem. 2009 Nov 12;52(21):6515-8.
4 Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2). Medchemcomm. 2012 Jun 1;3(6):699-709.